GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Price-to-Operating-Cash-Flow

Sino Biopharmaceutical (Sino Biopharmaceutical) Price-to-Operating-Cash-Flow

: 8.29 (As of Today)
View and export this data going back to 2010. Start your Free Trial

As of today (2024-04-19), Sino Biopharmaceutical's share price is $0.31495. Sino Biopharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.04. Hence, Sino Biopharmaceutical's Price-to-Operating-Cash-Flow Ratio for today is 8.29.

The historical rank and industry rank for Sino Biopharmaceutical's Price-to-Operating-Cash-Flow or its related term are showing as below:

SBMFF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.6   Med: 17.72   Max: 32.64
Current: 7.51

During the past 13 years, Sino Biopharmaceutical's highest Price-to-Operating-Cash-Flow Ratio was 32.64. The lowest was 6.60. And the median was 17.72.

SBMFF's Price-to-Operating-Cash-Flow is ranked better than
86.22% of 283 companies
in the Biotechnology industry
Industry Median: 24.39 vs SBMFF: 7.51

Sino Biopharmaceutical's Cash Flow from Operations per share for the six months ended in Jun. 2023 was $0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.04.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sino Biopharmaceutical was -32.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 5.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 15.90% per year.

During the past 13 years, Sino Biopharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 77.80% per year. The lowest was -31.20% per year. And the median was 15.30% per year.


Sino Biopharmaceutical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sino Biopharmaceutical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.08 22.47 16.01 12.42 -

Sino Biopharmaceutical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.01 - 12.42 - -

Competitive Comparison

For the Biotechnology subindustry, Sino Biopharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biopharmaceutical Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Price-to-Operating-Cash-Flow falls into.



Sino Biopharmaceutical Price-to-Operating-Cash-Flow Calculation

Sino Biopharmaceutical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.31495/0.038
=8.29

Sino Biopharmaceutical's Share Price of today is $0.31495.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sino Biopharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Sino Biopharmaceutical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Traded in Other Exchanges
Address
1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Sino Biopharmaceutical (Sino Biopharmaceutical) Headlines

From GuruFocus

GuruFocus Value Idea Contest Sees 2 Winners!

By Holly LaFon Holly LaFon 07-12-2019

Matthews China Fund Comments on Sino Biopharmaceutical

By Vera Yuan Vera Yuan 10-20-2014

Matthews China Fund 3rd Quarter Commentary

By Holly LaFon Holly LaFon 10-19-2017

Matthews China Fund Comments on Sino Biopharmaceutical

By Sydnee Gatewood Sydnee Gatewood 10-25-2019

Matthews China Fund Comments on Sino Biopharmaceutical

By Sydnee Gatewood Sydnee Gatewood 01-28-2020

Value Idea Contest: Sino Biopharmaceutical

By Matthew Sipos Matthew Sipos 01-10-2019